664341-72-4

Basic information

• Product Name: Carbamic acid, [(1S,3R)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl
• Synonyms: Carbamic acid, [(1S,3R)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl
• CAS NO: 664341-72-4
• Molecular Formula: C₁₁H₂₁NO₃
• Molecular Weight: 215.28934
• Product Categories: N-BOC
• Mol File: 664341-72-4.mol
• Article Data: 9

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Carbamic acid, [(1S,3R)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl(CAS DataBase Reference)
• NIST Chemistry Reference: Carbamic acid, [(1S,3R)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl(664341-72-4)
• EPA Substance Registry System: Carbamic acid, [(1S,3R)-3-(hydroxymethyl)cyclopentyl]-, 1,1-dimethylethyl(664341-72-4)

Safety Data

• Hazardous Substances Data: 664341-72-4(Hazardous Substances Data)

Upstream product

• 204913-00-8 (1R,4S)-tert-butyl 3-oxo-2-azabicyclo[2.2.1]heptane-2-carboxylate 
• 24424-99-5 di-tert-butyl dicarbonate 
• 79200-56-9 (-)-2-azabicyclo[2.2.1]hept-5-en-3-one 
• 134003-03-5 (+)-2-Azabicyclo<2.2.1>heptan-3-one 
• 147698-14-4 (1S,4R)-N-(9-Phenylfluoren-9-yl)-2-azabicyclo<2.2.1>heptan-3-one 
• 493039-08-0 methyl (4S)-4-[N-(9-phenyl-9-fluorenyl)amino]-1-cyclopentenecarboxylate 
• 161660-94-2 (1R,3S)-3-((tert-butoxycarbonyl)amino)cyclopentane-1-carboxylic acid 
• 130931-83-8 (1S,4R)-2-azabicyclo[2,2,1]hept-5-en-3-one 
• 49805-30-3 racemic 2-azabicyclo[2.2.1]hept-5-en-3-one 
• 108999-93-5 (1SR,4RS)-4-[(tert-butyloxycarbonyl)amino]cyclopent-2-enecarboxylic acid 
• 151792-53-9 tert-butyl (1R,4S)-(-)-3-oxo-2-azabicyclo[2.2.1]hept-5-ene-2-carboxylate 

Downstream Products

• 117957-62-7 (1S,3R)-1-amino-3-(hydroxymethyl)cyclopentanone 
• 859147-59-4 N-1-{(1S,4R)-4-(hydroxymethyl)cyclopentyl}-5'-O-{bis(phenylthio)phosphoryl}-2',3'-O-isopropylideneadenosine 
• 859147-55-0 N-1-[(1S,4R)-4-{(monomethoxytrityl)oxymethyl}cyclopentyl]-2',3'-O-isopropylideneadenosine 
• 859147-53-8 N-1-[(1S,4R)-4-{(monomethoxytrityl)oxymethyl}cyclopentyl]-5'-O-(tert-butyldimethylsilyl)-2',3'-O-isopropylideneadenosine 
• 859147-57-2 N-1-[(1S,4R)-4-{(monomethoxytrityl)oxymethyl}cyclopentyl]-5'-O-{bis(phenylthio)phosphoryl}-2',3'-O-isopropylideneadenosine 
• 664341-76-8 (8R)-3-[3-(tert-butyldiphenylsilyl)oxy]methylcyclopentyl-8-[(tert-butyldimethylsilyl)oxy]-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepine 
• 664341-74-6 5-[2-azido-1-(tert-butyl-dimethyl-silanyloxy)-ethyl]-3-[3-(tert-butyl-diphenyl-silanyloxymethyl)-cyclopentyl]-3H-imidazol-4-ylamine 
• 862701-82-4 N₁-boc-(1S,3R)-3-(4-cyanophenoxymethyl)cyclopentan-1-amine 
• 862701-78-8 N₁-boc-(3R,1S)-3-(4-nitrophenoxymethyl)cyclopentan-1-amine 

Relevant articles and documents

Synthesis and evaluation of cyclopentane-based muraymycin analogs targeting MraY

Antibiotic resistance is one of the most challenging global health issues and presents an urgent need for the development of new antibiotics. In this regard, phospho-MurNAc-pentapeptide translocase (MraY), an essential enzyme in the early stages of peptid

Indoleamine 2, 3-dioxygenase inhibitor and use thereof

The invention belongs to the technical field of medical technology and relates to a compound shown in the formula I and its pharmaceutically acceptable salt, isomer and prodrug. In the formula, R1, R2, R3, X, m, n and a ring A are defined in the specifica

NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS; PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM

The present invention relates to novel organic compounds, more particularly, novel Dipeptidyl peptidase IV (DPP-IV) inhibitors of general formula (I) wherein: Y is -S(O)m-, -CH2-, -CHF-, or -CF2; X and Z are independently -C(=O)-, -NR3-, - O- or -S(O)m-; each occurrence of m is independently 0, 1 or 2; a is 0, 1 or 2; b is 0, 1 or 2; the dotted line [----] in the carbocyclic ring represents an optional double bond; R1 is substituted or unsubstituted alkyl, substituted or unsubstituted alkenyl, substituted or unsubstituted alkynyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted cycloalkylalkyl, substituted or unsubstituted cycloalkenyl, substituted or unsubstituted aryl, substituted or unsubstituted arylalkyl, substituted or unsubstituted heteroaryl, substituted or unsubstituted heterocyclic ring, substituted or unsubstituted heterocyclylalkyl, or substituted or unsubstituted heteroarylalkyl; R2 is hydrogene, nitrile (-CN), COOH, or an isostere of carboxylic; or analogs, tautomers, enantiomers, diastereomers, regioisomers, stereoisomers, polymorphs, pharmaceutically acceptable salts, N-oxides, pharmaceutically acceptable solvates and pharmaceutical compositions containing them.